Literature DB >> 2369427

The eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

L E Shulman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2369427     DOI： 10.1002/art.1780330701

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

2.  Childhood eosinophilic fasciitis presenting as inflammatory polyarthritis and associated with selective IgA deficiency.

Authors:  D W Ching; J P Petrie
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.

Authors:  H Barth; R Klein; P A Berg
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

Authors:  J Adachi; K Yamamoto; Y Ogawa; Y Ueno; Y Mizoi; Y Tatsuno
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  R Klein; P A Berg
Journal:  Clin Investig       Date:  1994-07

6.  Eosinophilic fasciitis presenting as psoriatic arthropathy.

Authors:  G D Wright; C Thornton; D A Keegan; A L Bell
Journal:  Ulster Med J       Date:  1992-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.